Menu Menu

About FEEVA

A four year collaborative project developing methods for assessing preclinical evidence for vaccine development.

Latest News

Share your feedback on our updated Pregnancy Guidelines and Postnatal Care Guidelines
Survey Invitation: Platform for Living guidelines Usability Study (PLUS)
Study Invitation: Describing Policymaker Engagement in the Development of Clinical Practice Guidelines
Shaping the future of maternity care with Dr Nisha Khot: the challenges and rewards of producing Australia’s first living guidelines for Pregnancy and Postnatal Care
Trust and reciprocity shine through as key themes of consumer engagement in developing guidelines

This project will develop a framework of evidence and consensus based practical tools for the planning and assessment of indirect evidence for vaccines.

Evidence Mapping: we've created systematic evidence tools that display all the available evidence relevant to a specific research question or topic

UNSW Kirby Institute

FEEVA is a multidisciplinary collaboration between the Kirby Institute's Infection Analytics Program at the University of NSW and ALEC

What we do

A Framework for Evidence Evaluation in Vaccine Approval (FEEVA) is a four year project in collaboration with the Kirby Institute. Working with expert researchers, vaccine developers, regulators, and evidence synthesisers, this project will develop a set of evidence and consensus based practical tools to apply in both the planning and assessment of indirect evidence (pre-clinical or early clinical evidence) in vaccine development.
Our Team
Kirby Institute
Australian Living Evidence Collaboration
- Tari Turner
- Tsharni Zazryn
- Amy Moore
- Heath White
- Kim Jachno
- Loyal Pattuwage
Partners and Funders

Our Partners and Funders will be publicised shortly.
Contact FEEVA

FEEVA is a collaboration between the Kirby Institute and ALEC.

Contact us by emailing: [email protected]

Partners